RANDAL J KIRK Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Chairman, President and CEO in NEW RIVER PHARMACEUTICALS INC ($NRPH).

Latest Insider Trading Transactions of RANDAL J KIRK

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, NOVI, GYHT, NRPH

Page: 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 20 2010	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	0.00	15,200	0	2,326,687	2.3 M to 2.3 M (+0.66 %)
May 10 2010	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Grant	A	0.00	20,000	0	3,410,000	3.4 M to 3.4 M (+0.59 %)
Sep 21 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	0.00	18,000	0	2,311,487	2.3 M to 2.3 M (+0.78 %)
May 08 2009	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Grant	A	0.00	20,000	0	3,390,000	3.4 M to 3.4 M (+0.59 %)
Feb 27 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	P	8.18	3,055,300	24,999,992	3,055,300
Feb 27 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	P	8.18	3,055,300	24,999,992	3,055,300
Feb 27 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	P	9.74	763,825	7,442,711	763,825
Feb 27 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	P	9.74	763,825	7,442,711	763,825
Feb 27 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	P	8.12	763,825	6,202,259	763,825
Feb 27 2009	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	P	8.12	763,825	6,202,259	763,825
Jul 14 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Option Exercise	X	1.75	136,300	238,525	0
Jul 14 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	X	1.75	136,300	238,525	1,436,186	1.3 M to 1.4 M (+10.49 %)
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	12,120	199,253	12,120
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	24,239	398,489	24,239
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	24,239	398,489	24,239
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	121,194	1,992,429	121,194
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	60,597	996,215	60,597
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	302,983	4,981,041	302,983
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	A	16.44	212,089	3,486,743	212,089
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	24,240	400,021	24,240	0 to 24.2 K
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	48,478	800,008	48,478	0 to 48.5 K
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	48,478	800,008	48,478	0 to 48.5 K
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	242,388	4,000,008	242,388	0 to 242.4 K
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	121,194	2,000,004	183,772	62.6 K to 183.8 K (+193.67 %)
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	605,966	9,999,954	1,626,722	1 M to 1.6 M (+59.36 %)
Sep 30 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	16.50	424,178	6,999,997	2,063,458	1.6 M to 2.1 M (+25.88 %)
Sep 25 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	0.00	18,334	0	1,639,280	1.6 M to 1.6 M (+1.13 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.51	1,500	8,265	1,299,886	1.3 M to 1.3 M (+0.12 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.52	500	2,760	1,298,386	1.3 M to 1.3 M (+0.04 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.53	3,300	18,249	1,297,886	1.3 M to 1.3 M (+0.25 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.55	22,344	124,009	1,294,586	1.3 M to 1.3 M (+1.76 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.57	819	4,562	1,272,242	1.3 M to 1.3 M (+0.06 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Option Exercise	P	1.75	136,300	238,525	136,300
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.58	200	1,116	1,271,423	1.3 M to 1.3 M (+0.02 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.59	300	1,677	1,271,223	1.3 M to 1.3 M (+0.02 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.60	4,271	23,918	1,270,923	1.3 M to 1.3 M (+0.34 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.61	4,200	23,562	1,266,652	1.3 M to 1.3 M (+0.33 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.62	10,400	58,448	1,262,452	1.3 M to 1.3 M (+0.83 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.63	9,100	51,233	1,252,052	1.2 M to 1.3 M (+0.73 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.64	136,761	771,332	1,242,952	1.1 M to 1.2 M (+12.36 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.65	13,092	73,970	1,106,191	1.1 M to 1.1 M (+1.20 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.66	9,800	55,468	1,093,099	1.1 M to 1.1 M (+0.90 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.67	10,808	61,281	1,083,299	1.1 M to 1.1 M (+1.01 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.68	6,700	38,056	1,072,491	1.1 M to 1.1 M (+0.63 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.69	6,400	36,416	1,065,791	1.1 M to 1.1 M (+0.60 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.70	24,100	137,370	1,059,391	1 M to 1.1 M (+2.33 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.71	23,504	134,208	1,035,291	1 M to 1 M (+2.32 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.72	1,496	8,557	1,011,787	1 M to 1 M (+0.15 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.78	5,000	28,900	1,010,291	1 M to 1 M (+0.50 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.79	1,200	6,948	1,005,291	1 M to 1 M (+0.12 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.80	6,220	36,076	1,004,091	997.9 K to 1 M (+0.62 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.81	1,300	7,553	997,871	996.6 K to 997.9 K (+0.13 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.82	1,200	6,984	996,571	995.4 K to 996.6 K (+0.12 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.83	7,000	40,810	995,371	988.4 K to 995.4 K (+0.71 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.84	3,080	17,987	988,371	985.3 K to 988.4 K (+0.31 %)
Jun 25 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.93	427,100	2,532,703	985,291	558.2 K to 985.3 K (+76.52 %)
Jun 23 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.85	175,500	1,026,675	558,191	382.7 K to 558.2 K (+45.86 %)
Jun 23 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	6.02	59,900	360,598	382,691	322.8 K to 382.7 K (+18.56 %)
Jun 18 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.76	36,827	212,124	322,791	286 K to 322.8 K (+12.88 %)
Jun 18 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.98	42,000	251,160	285,964	244 K to 286 K (+17.22 %)
Jun 18 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.73	25,800	147,834	243,964	218.2 K to 244 K (+11.83 %)
Jun 13 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.53	45,725	252,859	218,164	172.4 K to 218.2 K (+26.52 %)
Jun 13 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.42	57,000	308,940	172,439	115.4 K to 172.4 K (+49.38 %)
Jun 13 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.27	115,439	608,364	115,439	0 to 115.4 K
May 12 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Option Exercise	A	4.94	10,000	49,400	10,000
May 12 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Grant	A	0.00	15,000	0	370,000	355 K to 370 K (+4.23 %)
Jun 23 2008	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	16.49	5,985	98,693	3,380,985	3.4 M to 3.4 M (+0.18 %)
Mar 24 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	6.06	580,000	3,514,800	6,328,853	5.7 M to 6.3 M (+10.09 %)
Mar 24 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	6.12	684,657	4,190,101	5,748,853	5.1 M to 5.7 M (+13.52 %)
Mar 20 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.80	886,650	5,142,570	5,064,196	4.2 M to 5.1 M (+21.22 %)
Mar 20 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	4.57	207,546	948,485	4,177,546	4 M to 4.2 M (+5.23 %)
Mar 20 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	5.80	886,650	5,142,570	5,064,196	4.2 M to 5.1 M (+21.22 %)
Mar 20 2008	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	4.57	207,546	948,485	4,177,546	4 M to 4.2 M (+5.23 %)
Oct 03 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	0.00	20,460	0	1,620,946	1.6 M to 1.6 M (+1.28 %)
Sep 20 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	9.00	23,085	207,765	3,970,000	3.9 M to 4 M (+0.58 %)
Sep 20 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	8.87	15,489	137,387	3,946,915	3.9 M to 3.9 M (+0.39 %)
Sep 17 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	8.66	238,020	2,061,253	3,931,426	3.7 M to 3.9 M (+6.44 %)
Sep 17 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	8.71	127,693	1,112,206	3,693,406	3.6 M to 3.7 M (+3.58 %)
Sep 17 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	8.74	65,713	574,332	3,565,713	3.5 M to 3.6 M (+1.88 %)
Jul 19 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	22.00	2,250,000	49,500,000	2,250,000	0 to 2.3 M
Jun 01 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	P	9.17	3,500,000	32,095,000	3,500,000	0 to 3.5 M
May 17 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Option Exercise	A	10.37	10,000	103,700	10,000
May 17 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Grant	A	10.37	15,000	155,550	355,000	340 K to 355 K (+4.41 %)
Jan 31 2007	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Option Exercise	A	56.39	298,200	16,815,498	298,200
Mar 15 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	7.91	11,960	94,604	522,460	510.5 K to 522.5 K (+2.34 %)
Mar 15 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	7.91	18,240	144,278	1,326,320	1.3 M to 1.3 M (+1.39 %)
Mar 15 2007	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	7.93	46,080	365,414	1,308,080	1.3 M to 1.3 M (+3.65 %)
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	X	19.45	13,329	259,249	0
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	X	19.45	48,252	938,501	0
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	X	19.45	31,833	619,152	0
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	X	19.45	37,670	732,682	0
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	X	19.45	50,400	980,280	0
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Option Exercise	X	19.45	2,876	55,938	0
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	X	19.45	13,329	259,249	193,343	180 K to 193.3 K (+7.40 %)
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	X	19.45	48,252	938,501	699,918	651.7 K to 699.9 K (+7.40 %)
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	X	19.45	31,833	619,152	461,745	429.9 K to 461.7 K (+7.40 %)
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	X	19.45	37,670	732,682	680,504	642.8 K to 680.5 K (+5.86 %)
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	X	19.45	50,400	980,280	731,083	680.7 K to 731.1 K (+7.40 %)
Feb 27 2007	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	X	19.45	2,876	55,938	41,719	38.8 K to 41.7 K (+7.40 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	35,284	1,701,737	1,471,806	1.5 M to 1.5 M (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	54,887	2,690,045	1,507,090	1.6 M to 1.5 M (-3.51 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	138,198	6,665,248	5,764,637	5.9 M to 5.8 M (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	214,975	10,536,054	5,902,835	6.1 M to 5.9 M (-3.51 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	35,151	1,695,322	1,466,218	1.5 M to 1.5 M (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	54,678	2,679,802	1,501,369	1.6 M to 1.5 M (-3.51 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	105,849	5,105,066	4,415,278	4.5 M to 4.4 M (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	164,655	8,069,840	4,521,127	4.7 M to 4.5 M (-3.51 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	28,353	1,367,457	1,182,665	1.2 M to 1.2 M (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	44,104	2,161,564	1,211,018	1.3 M to 1.2 M (-3.51 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	35,916	1,732,218	1,498,144	1.5 M to 1.5 M (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	55,868	2,738,124	1,534,060	1.6 M to 1.5 M (-3.51 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	48.23	12,554	605,476	523,650	536.2 K to 523.7 K (-2.34 %)
Nov 13 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	49.01	19,528	957,079	536,204	555.7 K to 536.2 K (-3.51 %)
Dec 11 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	6.16	80,000	492,800	1,262,000	1.2 M to 1.3 M (+6.77 %)
Dec 11 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	5.55	336,200	1,865,910	1,182,000	845.8 K to 1.2 M (+39.75 %)
Dec 06 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.84	53,500	151,940	845,800	792.3 K to 845.8 K (+6.75 %)
Dec 06 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.86	11,500	32,890	792,300	780.8 K to 792.3 K (+1.47 %)
Sep 18 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.50	102,500	256,250	780,800	678.3 K to 780.8 K (+15.11 %)
Sep 18 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.50	20,000	50,000	678,300	658.3 K to 678.3 K (+3.04 %)
Sep 13 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.50	74,000	185,000	658,300	584.3 K to 658.3 K (+12.66 %)
Sep 13 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.58	20,000	51,600	584,300	564.3 K to 584.3 K (+3.54 %)
Sep 13 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.54	3,200	8,128	564,300	561.1 K to 564.3 K (+0.57 %)
Sep 08 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.52	30,500	76,860	561,100	530.6 K to 561.1 K (+5.75 %)
Sep 08 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.51	15,000	37,650	530,600	515.6 K to 530.6 K (+2.91 %)
Sep 08 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.56	17,300	44,288	515,600	498.3 K to 515.6 K (+3.47 %)
Aug 29 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.60	23,000	59,800	498,300	475.3 K to 498.3 K (+4.84 %)
Aug 29 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.56	60,000	153,600	475,300	415.3 K to 475.3 K (+14.45 %)
Aug 29 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.50	110,900	277,250	415,300	304.4 K to 415.3 K (+36.43 %)
Aug 24 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.50	93,300	233,250	304,400	211.1 K to 304.4 K (+44.20 %)
Aug 24 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.49	6,700	16,683	211,100	204.4 K to 211.1 K (+3.28 %)
Aug 24 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.46	17,600	43,296	204,400	186.8 K to 204.4 K (+9.42 %)
Aug 21 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.46	12,500	30,750	186,800	174.3 K to 186.8 K (+7.17 %)
Aug 21 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.42	3,500	8,470	174,300	170.8 K to 174.3 K (+2.05 %)
Aug 21 2006	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Buy	P	2.46	94,100	231,486	170,800	76.7 K to 170.8 K (+122.69 %)
Sep 25 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Grant	A	0.00	10,800	0	1,066,991	1.1 M to 1.1 M (+1.02 %)
Sep 15 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	15.42	30,571	471,405	642,834	612.3 K to 642.8 K (+4.99 %)
Sep 08 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	14.95	42,000	627,900	612,263	570.3 K to 612.3 K (+7.37 %)
Aug 29 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	15.00	12,621	189,315	570,263	557.6 K to 570.3 K (+2.26 %)
Aug 29 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	15.07	13,990	210,829	557,642	543.7 K to 557.6 K (+2.57 %)
Aug 29 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	13.48	7,697	103,756	543,652	536 K to 543.7 K (+1.44 %)
Aug 24 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	13.17	10,693	140,827	535,955	525.3 K to 536 K (+2.04 %)
Aug 24 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	12.97	12,500	162,125	525,262	512.8 K to 525.3 K (+2.44 %)
Aug 24 2006	NOVI	CLINICAL DATA INC	KIRK RANDAL J	Director	Buy	P	12.30	4,012	49,348	512,762	508.8 K to 512.8 K (+0.79 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	70,684	2,367,914	1,561,977	1.6 M to 1.6 M (-4.33 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	276,847	9,274,375	6,117,810	6.4 M to 6.1 M (-4.33 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	70,415	2,358,903	1,556,047	1.6 M to 1.6 M (-4.33 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	212,044	7,103,474	4,685,782	4.9 M to 4.7 M (-4.33 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	56,798	1,902,733	1,255,122	1.3 M to 1.3 M (-4.33 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	71,948	2,410,258	1,589,928	1.7 M to 1.6 M (-4.33 %)
Apr 21 2006	NRPH	NEW RIVER PHARMACE ...	KIRK RANDAL J	Chairman, President ...	Sell	S	33.50	25,148	842,458	555,732	580.9 K to 555.7 K (-4.33 %)

Page: 1 2 3 next >